Advertisement
Home Tags Diabetes: Misc.

Tag: Diabetes: Misc.

Mini-group visits yield good results among patients with diabetes

Success Seen With Mini-Group Visits for Patients With Diabetes

0
Visits usually involve three patients; do not replace individual office visits, but augment them
Botulinum toxin-A appears to be beneficial for painful diabetic neuropathy

Botulinum Toxin-A Beneficial in Painful Diabetic Neuropathy

0
Meta-analysis of two studies shows clinically significant improvement of 'minimum change in pain'

March 2015 Briefing – Diabetes & Endocrinology

0
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for March 2015. This roundup includes...
Arsenic metabolism is prospectively associated with diabetes incidence

Arsenic Metabolism Linked to Diabetes Incidence

0
Lower proportion of monomethylarsonate linked to higher incidence of diabetes
When used to treat gestational diabetes

Glyburide in Gestational DM Linked to Complications

0
Associated with more infant intensive care and respiratory distress
Women with diabetes may have an increased risk of being diagnosed with advanced breast cancer

Diabetes May Predispose to More Advanced Breast Cancer

0
Findings suggest need to modify screening methods
African-Americans have a moderately high prevalence of subclinical disease

Prevalence of Subclinical Disease ID’d in African-Americans

0
Prevalence 26 percent; increased odds of disease among those with metabolic syndrome, diabetes
A cardiovascular disease risk equation has been developed that can be recalibrated for application in different countries

Cardiovascular Disease Risk Equation Can Be Applied Globally

0
Risk equation can be recalibrated for application in different countries; good discrimination in validations
Medicaid expansion is associated with an increase in diabetes diagnosis

Newly Identified Diabetes Up With Medicaid Expansion

0
Twenty-three percent increase in newly identified diabetes in 26 states that expanded Medicaid
U.S. Food and Drug Administration approval of Eylea (aflibercept) has been expanded to treat diabetic retinopathy among people with diabetic macular edema

FDA: Eylea Approval Expanded to Include Diabetic Retinopathy

0
Among people with diabetic macular edema